Scientists from Uppsala University and several other research institutions have created a personalized human liver model that can significantly improve the diagnosis and treatment of diseases such as ...
On Dec. 5, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted to end the ...
Recent scientific studies are connecting Coca-Cola consumption to severe health conditions including fatty liver disease, ...
Seven weeks ago, Alison Kavanaugh made the decision to donate part of her liver to her sister, whose liver was failing from a ...
Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...
Scientists at City of Hope have unraveled how citrin deficiency (CD), a rare genetic disorder that prevents the liver from ...
A Morris County-based pharmaceutical company is laying off nearly 150 employees after a medication it created was linked to ...
CT BUZZ’s Mackenzie Maynard welcomed  Dr. Housein Waziz, a physician with MidState Gastroenterology Specialists,  for a ...
Chennai: Kauvery Hospital, Vadapalani, has launched the Kauvery Institute of Digestive Sciences, a specialised initiative ...
Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.
In 2025, national gastroenterology and hepatology organizations recognized physicians whose work is advancing digestive disease research, clinical care, education and innovation. These five GI leaders ...